Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has granted a rolling new drug application (NDA) submission for suzetrigine (formerly known as VX-548) in moderate-to-severe acute pain....
Source LinkVertex Pharmaceuticals Incorporated VRTX announced that the FDA has granted a rolling new drug application (NDA) submission for suzetrigine (formerly known as VX-548) in moderate-to-severe acute pain....
Source Link
Comments